Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320372 · ClinicalTrials.gov registry record
Treatment-Resistant Depression Registry
A clinical trial, sponsored by Cyberonics.
- Completed
- Registry status
- 795
- Enrollment target
NCT00320372 is a clinical trial that has completed, run by Cyberonics. The registered enrollment target is 795 participants.
The verdict
NCT00320372 has completed, sponsored by Cyberonics.
- COMPLETED
- Registry status
- 795 participants
- Enrollment target
Study Summary
This registry will collect information about patients with treatment-resistant depression (TRD) who are currently in a major depressive episode. For the purposes of this study, TRD is defined as an ongoing depression lasting at least 2 years or that has recurred at least 3 times, to include the current episode, during the patient's lifetime AND has not adequately responded to 4 or more adequate antidepressive treatments. The registry will follow the clinical course and outcomes for patients with TRD who are treated with and without adjunctive (used along with other treatments for depression) vagus nerve stimulation (VNS) therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 795 participants |
| Start Date | 2006-01 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00320372
The ClinicalTrials.gov registry entry for NCT00320372 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 795 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cyberonics, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00320372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00320372 about?
NCT00320372 is a clinical study titled "Treatment-Resistant Depression Registry". This registry will collect information about patients with treatment-resistant depression (TRD) who are currently in a major depressive episode. For the purposes of this study, TRD is defined as an ongoing depression lasting at least 2 years or that has recurred at least 3 times, to include the curr...
What is the current status of trial NCT00320372?
This trial is currently completed. The enrollment target is 795 participants. The study started on 2006-01. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT00320372?
This trial is sponsored by Cyberonics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.